Goal #3: Address health needs of populations

On Friday, November 21, 2025, the Indiana CTSI convened researchers, clinicians, trainees, community partners, and industry collaborators for its Annual Meeting under the theme “Moving the Needle: Treating Diabetes Together.” They met in the Hine Hall auditorium on the IU Indianapolis campus.&nbsp;Building on tradition, but with a focused lens&nbsp; The 2025 program addressed new advances in treating diabetes. Approximately 12% of Hoosiers have diabetes, and Indiana has a long legacy of innovation in diabetes treatment, dating back to Eli Lilly and Company’s commercialization of insulin production in the early 1920s. This year’s Annual Meeting tapped into both the challenges and the opportunities in addressing this major public health challenge.&nbsp;Recognizing Kevan Herold, MD&nbsp; Keynote speaker Kevan Herold, MD, of Yale School of Medicine, received the 2025 August M. Watanabe Prize in Translational Research. He was recognized for his significant achievements in translational immunology, including the development of the first immune therapy shown to delay the onset of type 1 diabetes. (Read more about Herold’s impact.)His keynote address, titled “Charting the Way to Prevention and Reversal of Type 1 Diabetes,” offered insights into immunobiology, translational therapies for type 1 diabetes, and how collaboration across disciplines may advance the field. Q&amp;A was moderated by Tatiana Foroud, PhD, executive associate dean for Research Affairs at Indiana University School of Medicine.

Indiana Clinical and Translational Sciences Institute

Slideshow title slide "Welcome to the Indiana CTSI 2025 Annual Meeting"

large_2025-annual-meeting-welcome-slide-1536x1024.jpg

medium_2025-annual-meeting-welcome-slide-1536x1024.jpg

small_2025-annual-meeting-welcome-slide-1536x1024.jpg

thumbnail_2025-annual-meeting-welcome-slide-1536x1024.jpg

2025-annual-meeting-welcome-slide-1536x1024.jpg

Explore highlights from the Indiana CTSI 2025 Annual Meeting, where experts and partners gathered to advance diabetes treatment under the theme “Moving the Needle: Treating Diabetes Together.” The event featured keynote speaker Kevan Herold, M.D., honored for groundbreaking work in immune therapy and type 1 diabetes research, and sparked new collaborations to address this critical public health challenge. Read the full article for insights and inspiration from this leading-edge event.

Indiana CTSI Annual Meeting "Moves the Needle" on Diabetes

- Any -

Goal #7:  Training and career support programs for translational scientists

Develop the intellectual framework and technical skills to ensure the rigor and reproducibility of biomedical and healthcare research with cutting-edge data science and artificial intelligence (AI) methods.Open to university faculty and research scientists.Participation in the training program is free of charge. Scholarships are available.For more information, visit our FAQ.Session #1Monday, May 18 – Saturday, May 23, 2026University of Michigan – Ann Arbor, MISession #2Monday, June 8– Saturday, June 13, 2026University Texas San Antonio – San Antonio, TX

National Institutes of Health (NIH)

small_DAIR3.png

thumbnail_DAIR3.png

DAIR3.png

Develop the intellectual framework and technical skills to ensure the rigor and reproducibility of biomedical and healthcare research with cutting-edge data science and artificial intelligence (AI) methods.Open to university faculty and research scientists.Participation in the training program is free of charge. Scholarships are available.For more information, visit our <a href="https://dair-3.org/faq/" target="_blank" rel="noopener noreferrer">FAQ</a>.Session #1Monday, May 18 – Saturday, May 23, 2026University of Michigan – Ann Arbor, MISession #2Monday, June 8– Saturday, June 13, 2026University Texas San Antonio – San Antonio, TX

Data and AI Intensive Research with Rigor and Reproducibility (DAIR)

X-logo-teal_80x66.png

ri_linkedin_fill_408497d4b5_96748f4451.png

Gainesville, Fla. — Ninety-three percent of patients with a new cancer diagnosis were exposed to at least one type of misinformation about cancer treatments, a UF Health Cancer Center study has found.Most patients encountered the misinformation — defined as unproven or disproven cancer treatments and myths or misconceptions — even when they weren’t looking for it.The findings have major implications for cancer treatment decision-making. Specifically, doctors should assume the patient has seen or heard misinformation.“Clinicians should assume when their patients are coming to them for a treatment discussion that they have been exposed to different types of information about cancer treatment, whether or not they went online and looked it up themselves,” said senior author Carma Bylund, Ph.D., a professor and associate chair of education in the UF Department of Health Outcomes and Biomedical Informatics. “One way or another, people are being exposed to a lot of misinformation.”Working with oncologists, Bylund and study first author Naomi Parker, Ph.D., an assistant scientist in the UF Department of Health Outcomes and Biomedical Informatics, are piloting an “information prescription” to steer patients to sources of evidence-based information like the American Cancer Society. The study paves the way for other similar strategies.Most notably, the study found the most common way patients were exposed to misinformation was second hand.“Your algorithms pick up on your diagnosis, your friends and family pick up on it, and then you’re on Facebook and you become exposed to this media,” Parker said. “You’re not necessarily seeking out if vitamin C may be a cure for cancer, but you start being fed that content.”And no, vitamin C does not cure cancer.Health misinformation can prevent people from getting treatment that has evidence behind it, negatively affect relationships between patients and physicians, and increase the risk of death, research has shown. People with cancer are particularly vulnerable to misinformation because of the anxiety and fear that comes with a serious diagnosis, not to mention the overwhelming amount of new information they have to suddenly absorb.While past research has studied misinformation by going directly to the source — for instance, studying what percentage of content on a platform like TikTok is nonsense — little research has looked at its prevalence or how it affects people.The team first developed a way to identify the percentage of cancer patients exposed to misinformation. UF researchers collaborated with Skyler Johnson, M.D., at Huntsman Cancer Institute, an internationally known researcher in the field.The survey questions were based on five categories of unproven or disproven cancer treatments — vitamins and minerals, herbs and supplements, special diets, mind-body interventions and miscellaneous treatments — and treatment misconceptions. The myths and misconceptions were adapted from National Cancer Institute materials and included statements like “Will eating sugar make my cancer worse?”The team surveyed 110 UF Health patients diagnosed with prostate, breast, colorectal or lung cancer within the past six months, a time when patients typically make initial treatment decisions.Most had heard of a potential cancer treatment beyond the standard of care, and most reported they had heard of at least one myth or misconception. The most common sources were close friends or family and websites, distant friends/associates or relatives, social media and news media.The findings mark a shift in misinformation research, with major implications for the doctor-patient relationship, said Bylund, a member of the Cancer Control and Population Sciences research program at the UF Health Cancer Center.“I still think media and the internet are the source and why misinformation can spread so rapidly, but it might come to a cancer patient interpersonally, from family or friends,” she said.Most patients rarely discussed the potential cancer treatments they had heard about with an oncologist, the study also found.Next, the researchers plan to survey a wider pool of patients, then study the outcomes of interventions designed to decrease misinformation exposure, like the information prescription.

University of Florida Clinical and Translational Science Institute

large_Info-prescription2.jpg.webp

medium_Info-prescription2.jpg.webp

small_Info-prescription2.jpg.webp

thumbnail_Info-prescription2.jpg.webp

Info-prescription2.jpg.webp

University of Florida

Did you know nearly every newly diagnosed cancer patient encounters false or misleading information about treatments, even if they are not searching for it? A UF Health Cancer Center study uncovers how pervasive cancer treatment myths are and why doctors must address them proactively. Read the full article to see how UF researchers are tackling this challenge with new strategies to help patients access reliable, evidence-based information when it matters most.

CTSA CCOS

Home

About

CTSA Groups and Meetings

Resources

News

Help

CTSA News

Indiana CTSI Annual Meeting "Moves the Needle" on Diabetes

Summary

Article